This year's flu vaccine guards against new strains

September 27, 2012 by Lauran Neergaard

(AP)—Time to get your flu vaccine. And remember: Last year's shot won't protect you this year.

said Thursday that this year's vaccine contains protection against two different that have begun circling the globe. And just because flu was mild last winter, doesn't mean it won't bounce back with its usual ferocity this winter.

With 135 million doses expected, there's plenty of vaccine to go around.

Flu vaccination is recommended for virtually everyone older than 6 months of age. But the government says just 42 percent of Americans were immunized last year.

The good news is that three-quarters of babies and toddlers were vaccinated. But even though people 65 and older also are at very high risk, just two-thirds were vaccinated.

shares

Related Stories

Recommended for you

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.